Posts by Sandra Ansanay-Alex
Medical devices: Switzerland soon aligned with the FDA?
The Swiss government is working on a simplified validation procedure for medical devices that have already been authorised by the US FDA – involving private bodies in the assessment. During a session on 30 April 2025, the Federal Council has laid the groundwork for a wider supply of medical devices. The aim is…
Read MoreIlmac
Ilmac will take place from 23 to 24 September 2026 in Palais Beaulieu, Lausanne Every two years, Ilmac Lausanne is the largest meeting place for the chemical and life science industry in the Swiss Health Valley. Ilmac has its origins in the Swiss trade fair for international laboratory, measurement and automation technology in chemistry, which…
Read MoreAktiia closes a CHF 34 million Series B and becomes Hilo
Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by Earlybird Health and Wellington Partners, with new investors Kfund and naturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures. The investment, which has brought the total financing to…
Read MoreGESICA: Strengthening Cross-Border Health Crises Readiness
In an era marked by mounting pressure on healthcare systems and a growing number of exceptional public health emergencies, cross-border scientific collaboration has never been more critical. The GESICA project—GEstion des SItuations de Crises sAnitaires—is designed to address this challenge by enhancing the ability to detect, anticipate, and manage health crises across the France–Switzerland region.…
Read MoreBioscibex, Inkocell Therapeutics, and OrthoSens Supported By Venture Kick
Bioscibex, Inkocell Therapeutics, and OrthoSens were selected at Venture Kick’s second financial and entrepreneurial support stage and get each a CHF 40’000 support. These three Swiss Health Valley startups reshape biopharma, oncology, and orthopedic recovery. Bioscibex, Inkocell Therapeutics, and OrthoSens have progressed to the second stage of Venture Kick, securing support to drive their innovations…
Read MoreWorld Health Assembly
The Seventy-nine World Health Assembly is being held in Geneva, Switzerland, on 18–23 May 2026 The World Health Assembly is the decision-making body of WHO. It is attended by delegations from all WHO Member States and focuses on a specific health agenda prepared by the Executive Board. The main functions of the World Health…
Read MoreAerospec, Carewell, OptiZone and SaisiR Finalists of the PERL Prize
Four Swiss Health Valley start-ups selected from the 5 finalists in the 23rd Prix Entreprendre Lausanne Région (PERL): Aerospec, Carewell, OptiZone and SaisiR. Nearly 60 companies from the Lausanne region applied for the PERL 2025 awards. Only five have been selected for the Awards Ceremony, to be held on Wednesday 7 May, and only one…
Read MoreHealium, Hikane and LittleCubes Supported By FIT
These three new life sciences projects have each been awarded a FIT Impact grant of 10,000 CHF. Healium is developing Medicase, a compact and connected pill-dispenser designed to improve adherence to treatment. Designed for the visually impaired, Hikane is a compact device that attaches to any white cane and provides haptic feedback to signal the…
Read MoreHeroSupport Partners With Swiss Medical Network
HeroSupport, a HUG spin-off founded in 2022 by medical physicist Giovanna Dipasquale, is redefining breast cancer treatment with its 3D-printed, custom-made shells designed to improve the precision and comfort of radiotherapy. The Geneva-based startup has just announced a strategic partnership with Swiss Medical Network, a major milestone in its mission to enhance cancer care. …
Read MoreNagi Bioscience Partners With Rhino Bio Inc. To Expand In South Korea
Nagi Bioscience, a pioneering Swiss company specializing in cutting-edge laboratory technologies for alternative model organisms research, announced a strategic partnership with Rhino Bio Inc., a leading distributor for next–generation analytical systems in South Korea. The partnership accelerates Nagi Bioscience’s expansion into the South Korean market, driven by strong demand for its flagship product, SydLab™ One.…
Read More